The Value Impact of R&D Alliances in the Biotech Industry

Hady Farag () and Ulrich Hommel
Additional contact information
Hady Farag: The Boston Consulting Group (BCG)
Ulrich Hommel: European Business School

A chapter in Innovation and International Corporate Growth, 2010, pp 371-392 from Springer

Abstract: Abstract The extraordinary importance of collaboration for biotechnology manifests itself in an over-proportionally high frequency of alliance formation vis-à-vis other research-intensive industries. As Fig. 1 indicates, biotechnology accounted for over half of all technology alliances in the U.S., compared to having for instance only 7% of all R&D employees. That is, whereas other R&D-intensive industries rely on in-house research, alliances are an integral part of business models in biotechnology.

Keywords: Abnormal Return; Strategic Alliance; Event Window; Focal Firm; Announcement Date (search for similar items in EconPapers)
Date: 2010
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-642-10823-5_23

Ordering information: This item can be ordered from
http://www.springer.com/9783642108235

DOI: 10.1007/978-3-642-10823-5_23

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().